{"transactions":[{"id":4618660,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-09-15T22:57:31.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":1283,"price":13.57,"value":17410.31,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":67863,"source":{"system":"sec-edgar","filing":"0001193125-26-392233","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603347/000119312526392233/ownership.xml","form_type":"4"}},{"id":3414234,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-09-08T16:29:52.000Z","date":"2026-09-03","kind":"sale","planned":false,"acquired":false,"shares":161,"price":13.99,"value":2252.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 396 shares acquired under the Company's Amended and Restated Employee Stock Purchase Place on April 30, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":69146,"source":{"system":"sec-edgar","filing":"0001193125-26-384878","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603347/000119312526384878/ownership.xml","form_type":"4"}},{"id":800770,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-24T20:39:40.000Z","date":"2026-04-22","kind":"grant","planned":false,"acquired":true,"shares":7348,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":7348,"derivative":{"exercise_price":24.61,"expiration_date":"2036-04-22","underlying":"Common Stock","underlying_shares":7348},"source":{"system":"sec-edgar","filing":"0001193125-26-177470","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526177470/ownership.xml","form_type":"4"}},{"id":800769,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-04-24T20:39:40.000Z","date":"2026-04-22","kind":"grant","planned":false,"acquired":true,"shares":20241,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":68911,"source":{"system":"sec-edgar","filing":"0001193125-26-177470","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526177470/ownership.xml","form_type":"4"}},{"id":865574,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:51:08.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":1632,"price":22.8,"value":37209.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.54 to $23.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":48670,"source":{"system":"sec-edgar","filing":"0001193125-26-089109","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526089109/ownership.xml","form_type":"4"}},{"id":865573,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:51:08.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":148,"price":23.39,"value":3461.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."}],"balance_after":50302,"source":{"system":"sec-edgar","filing":"0001193125-26-089109","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312526089109/ownership.xml","form_type":"4"}},{"id":957018,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-12-30T18:49:27.000Z","date":"2025-12-29","kind":"sale","planned":false,"acquired":false,"shares":85,"price":34.38,"value":2922.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 293 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on October 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":50450,"source":{"system":"sec-edgar","filing":"0001193125-25-336619","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312525336619/ownership.xml","form_type":"4"}},{"id":1035432,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-09-19T22:23:43.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":64,"price":29.17,"value":1866.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":50242,"source":{"system":"sec-edgar","filing":"0001193125-25-209387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000119312525209387/ownership.xml","form_type":"4"}},{"id":1045623,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-09-08T18:01:44.000Z","date":"2025-09-05","kind":"sale","planned":false,"acquired":false,"shares":84,"price":31.39,"value":2636.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 266 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on April 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":50306,"source":{"system":"sec-edgar","filing":"0000950170-25-113446","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025113446/ownership.xml","form_type":"4"}},{"id":1226899,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-05T01:00:32.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":5632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":5632,"derivative":{"exercise_price":42.92,"expiration_date":"2035-03-01","underlying":"Common Stock","underlying_shares":5632},"source":{"system":"sec-edgar","filing":"0000950170-25-032764","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025032764/ownership.xml","form_type":"4"}},{"id":1226898,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-03-05T01:00:32.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":141,"price":42.92,"value":6051.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":50124,"source":{"system":"sec-edgar","filing":"0000950170-25-032764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025032764/ownership.xml","form_type":"4"}},{"id":1226897,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-03-05T01:00:32.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":967,"price":42.1,"value":40710.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.77 to $42.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":50265,"source":{"system":"sec-edgar","filing":"0000950170-25-032764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025032764/ownership.xml","form_type":"4"}},{"id":1226896,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-03-05T01:00:32.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":9392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date"}],"balance_after":51232,"source":{"system":"sec-edgar","filing":"0000950170-25-032764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025032764/ownership.xml","form_type":"4"}},{"id":1335208,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-12-11T23:47:11.000Z","date":"2024-12-10","kind":"gift","planned":false,"acquired":false,"shares":648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 237 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on October 31, 2024."}],"balance_after":41840,"source":{"system":"sec-edgar","filing":"0000950170-24-135525","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024135525/ownership.xml","form_type":"4"}},{"id":1403266,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-09-18T17:03:31.000Z","date":"2024-09-16","kind":"grant","planned":false,"acquired":true,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":42251,"source":{"system":"sec-edgar","filing":"0000950170-24-107677","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024107677/ownership.xml","form_type":"4"}},{"id":1413599,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-09-05T15:50:56.000Z","date":"2024-09-03","kind":"sale","planned":false,"acquired":false,"shares":91,"price":56.19,"value":5113.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 276 shares acquired under the Company's Amended and Restated 2014 Employee Stock Purchase Plan on April 30, 2024"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":41551,"source":{"system":"sec-edgar","filing":"0000950170-24-103807","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024103807/ownership.xml","form_type":"4"}},{"id":1539087,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-04-18T22:06:10.000Z","date":"2024-04-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":14,"price":42.31,"value":592.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":41366,"source":{"system":"sec-edgar","filing":"0000950170-24-045670","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024045670/ownership.xml","form_type":"4"}},{"id":1594524,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T01:13:18.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":2351,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 1, 2022, the Reporting Person was granted an option to purchase 2,351 shares of common stock. The option vests upon the achievement of specified performance criteria. Upon achievement of the performance criteria, 1/3 of the option vests on the date of certification by the Issuer's compensation committee of achievement of the performance criteria, 1/3 of the option vests on March 1, 2024 and 1/3 of the option vests on March 1, 2025. On March 1, 2024, the Issuer's compensation committee certified achievement of the performance criteria for the option, resulting in the vesting of the option of 1,568 shares on that date."}],"balance_after":2351,"derivative":{"exercise_price":67.37,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":2351},"source":{"system":"sec-edgar","filing":"0000950170-24-026641","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024026641/ownership.xml","form_type":"4"}},{"id":1594523,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T01:13:18.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":8200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":8200,"derivative":{"exercise_price":53.69,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":8200},"source":{"system":"sec-edgar","filing":"0000950170-24-026641","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024026641/ownership.xml","form_type":"4"}},{"id":1594522,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-03-06T01:13:18.000Z","date":"2024-03-01","kind":"sale","planned":false,"acquired":false,"shares":341,"price":53.76,"value":18332.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":41380,"source":{"system":"sec-edgar","filing":"0000950170-24-026641","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024026641/ownership.xml","form_type":"4"}},{"id":1594521,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-03-06T01:13:18.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":121,"price":53.69,"value":6496.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."}],"balance_after":41721,"source":{"system":"sec-edgar","filing":"0000950170-24-026641","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024026641/ownership.xml","form_type":"4"}},{"id":1594520,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-03-06T01:13:18.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":13950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date"}],"balance_after":41842,"source":{"system":"sec-edgar","filing":"0000950170-24-026641","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024026641/ownership.xml","form_type":"4"}},{"id":1696104,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-02T21:06:43.000Z","date":"2024-01-02","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter."}],"balance_after":0,"derivative":{"exercise_price":21,"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-24-000070","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919124000070/doc4.xml","form_type":"4"}},{"id":1696103,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-01-02T21:06:43.000Z","date":"2024-01-02","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":21,"value":63000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 278 shares acquired under the Company's Amended and Restated 2014 Employee Stock Purchase Plan on October 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":27892,"source":{"system":"sec-edgar","filing":"0001209191-24-000070","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919124000070/doc4.xml","form_type":"4"}},{"id":1696102,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-01-02T21:06:43.000Z","date":"2023-12-20","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."}],"balance_after":24614,"source":{"system":"sec-edgar","filing":"0001209191-24-000070","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919124000070/doc4.xml","form_type":"4"}},{"id":1771414,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-29T18:16:40.000Z","date":"2023-09-27","kind":"grant","planned":false,"acquired":true,"shares":2351,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 1, 2022, the Reporting Person was granted an option to purchase 2,351 shares of common stock. The option vests upon the achievement of specified performance criteria. Upon achievement of the performance criteria, 1/3 of the option vests on the date of certification by the Issuer's compensation committee of achievement of the performance criteria, 1/3 of the option vests on March 1, 2024 and 1/3 of the option vests on March 1, 2025. On September 27, 2023, the Issuer's compensation committee certified achievement of the performance criteria for the option, resulting in the vesting of the option of 784 shares on that date."}],"balance_after":2351,"derivative":{"exercise_price":67.37,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":2351},"source":{"system":"sec-edgar","filing":"0001209191-23-050841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123050841/doc4.xml","form_type":"4"}},{"id":1783724,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-11T17:52:12.000Z","date":"2023-09-07","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter."}],"balance_after":3000,"derivative":{"exercise_price":21,"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-23-048905","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123048905/doc4.xml","form_type":"4"}},{"id":1783723,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-09-11T17:52:12.000Z","date":"2023-09-07","kind":"sale","planned":false,"acquired":false,"shares":163,"price":38.34,"value":6249.42,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying restricted stock units granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":23614,"source":{"system":"sec-edgar","filing":"0001209191-23-048905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123048905/doc4.xml","form_type":"4"}},{"id":1783722,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-09-11T17:52:12.000Z","date":"2023-09-07","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":41,"value":82000.0,"ownership":{"direct":true},"balance_after":23777,"source":{"system":"sec-edgar","filing":"0001209191-23-048905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123048905/doc4.xml","form_type":"4"}},{"id":1783721,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-09-11T17:52:12.000Z","date":"2023-09-07","kind":"exercise","planned":false,"acquired":true,"shares":2000,"price":21,"value":42000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023."}],"balance_after":25777,"source":{"system":"sec-edgar","filing":"0001209191-23-048905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123048905/doc4.xml","form_type":"4"}},{"id":1786765,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-09-06T21:50:58.000Z","date":"2023-09-01","kind":"sale","planned":false,"acquired":false,"shares":87,"price":38.23,"value":3326.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The total amount of securities beneficially owned by the Reporting Person reflected in Table 1, Column 5 of this Form 4 reflects the correction of a typographical error in a previously filed Form 4 filed on April 18, 2023 (\"April 2023 Form 4\").  The corrected total amount of securities beneficially owned by the Reporting Person in Table 1, Column 5 of the April 2023 Form 4 is 21,520. The corrected total amount of securities beneficially owned by the Reported Person in Table 1, Column 5 of the Form 4 filed on behalf of the Reporting Person on May 10, 2023 is 24,747."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":23777,"source":{"system":"sec-edgar","filing":"0001209191-23-048489","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123048489/doc4.xml","form_type":"4"}},{"id":1786764,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-09-06T21:50:58.000Z","date":"2023-09-01","kind":"sale","planned":false,"acquired":false,"shares":883,"price":37.04,"value":32706.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this row of the Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023."}],"balance_after":23864,"source":{"system":"sec-edgar","filing":"0001209191-23-048489","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123048489/doc4.xml","form_type":"4"}},{"id":1897899,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-11T00:09:31.000Z","date":"2023-05-09","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter."}],"balance_after":5000,"derivative":{"exercise_price":21,"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-23-028585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123028585/doc4.xml","form_type":"4"}},{"id":1897898,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-05-11T00:09:31.000Z","date":"2023-05-09","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":21,"value":63000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 227 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":30747,"source":{"system":"sec-edgar","filing":"0001209191-23-028585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123028585/doc4.xml","form_type":"4"}},{"id":1917927,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-04-18T20:57:55.000Z","date":"2023-04-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":181,"price":38.2,"value":6914.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were acquired upon the partial vesting of a previously reported RSU and were sold to permit the cash value of the awards to be credited to the deferred compensation plan account of the Reporting Person"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":27520,"source":{"system":"sec-edgar","filing":"0001209191-23-024685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123024685/doc4.xml","form_type":"4"}},{"id":1917926,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-04-18T20:57:55.000Z","date":"2023-04-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":14,"price":38.2,"value":534.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."}],"balance_after":27701,"source":{"system":"sec-edgar","filing":"0001209191-23-024685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123024685/doc4.xml","form_type":"4"}},{"id":1972002,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-04T00:54:57.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":10120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":10120,"derivative":{"exercise_price":45.65,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":10120},"source":{"system":"sec-edgar","filing":"0001209191-23-016045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123016045/doc4.xml","form_type":"4"}},{"id":1972001,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-03-04T00:54:57.000Z","date":"2023-03-01","kind":"disposition_to_issuer","acquired":false,"shares":1333,"price":45.65,"value":60851.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares were acquired upon the partial vesting of a previously reported RSU and were sold to permit the cash value of the awards to be credited to the deferred compensation plan account of the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":21715,"source":{"system":"sec-edgar","filing":"0001209191-23-016045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123016045/doc4.xml","form_type":"4"}},{"id":1972000,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-03-04T00:54:57.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":100,"price":45.65,"value":4565.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."}],"balance_after":23048,"source":{"system":"sec-edgar","filing":"0001209191-23-016045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123016045/doc4.xml","form_type":"4"}},{"id":1971999,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-03-04T00:54:57.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":7590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."}],"balance_after":23148,"source":{"system":"sec-edgar","filing":"0001209191-23-016045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123016045/doc4.xml","form_type":"4"}},{"id":1978759,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-03-02T19:28:00.000Z","date":"2023-02-28","kind":"sale","acquired":false,"shares":639,"price":43.4,"value":27732.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":15558,"source":{"system":"sec-edgar","filing":"0001209191-23-014502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123014502/doc4.xml","form_type":"4"}},{"id":2077424,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-12-22T18:24:42.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":2031,"price":43.96,"value":89282.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 134 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 31, 2022"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":16197,"source":{"system":"sec-edgar","filing":"0001209191-22-062400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919122062400/doc4.xml","form_type":"4"}},{"id":2162914,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-09-08T22:36:29.000Z","date":"2022-09-01","kind":"grant","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 180 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":18094,"source":{"system":"sec-edgar","filing":"0001209191-22-049222","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919122049222/doc4.xml","form_type":"4"}},{"id":2294558,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-04-19T16:56:40.000Z","date":"2022-04-16","kind":"sale","acquired":false,"shares":132,"price":84.55,"value":11160.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":16914,"source":{"system":"sec-edgar","filing":"0001209191-22-024699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919122024699/doc4.xml","form_type":"4"}},{"id":2353059,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T23:09:56.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":7400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":7400,"derivative":{"exercise_price":67.37,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":7400},"source":{"system":"sec-edgar","filing":"0001209191-22-015819","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919122015819/doc4.xml","form_type":"4"}},{"id":2353058,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-03-03T23:09:56.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":3710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 107 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 29, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":17046,"source":{"system":"sec-edgar","filing":"0001209191-22-015819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919122015819/doc4.xml","form_type":"4"}},{"id":2353057,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-03-03T23:09:56.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":843,"price":66.62,"value":56160.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."}],"balance_after":13229,"source":{"system":"sec-edgar","filing":"0001209191-22-015819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919122015819/doc4.xml","form_type":"4"}},{"id":2540335,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-10-18T22:53:15.000Z","date":"2021-10-14","kind":"sale","acquired":false,"shares":140,"price":81.14,"value":11359.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":14072,"source":{"system":"sec-edgar","filing":"0001209191-21-060756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121060756/doc4.xml","form_type":"4"}},{"id":2540334,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-10-18T22:53:15.000Z","date":"2021-09-13","kind":"gift","acquired":false,"shares":819,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14212,"source":{"system":"sec-edgar","filing":"0001209191-21-060756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121060756/doc4.xml","form_type":"4"}},{"id":2720556,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-05-10T22:12:28.000Z","date":"2021-05-06","kind":"sale","acquired":false,"shares":142,"price":113.67,"value":16141.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 129 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":15031,"source":{"system":"sec-edgar","filing":"0001209191-21-031386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121031386/doc4.xml","form_type":"4"}},{"id":2744802,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-04-19T21:16:41.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":15044,"source":{"system":"sec-edgar","filing":"0001209191-21-027328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121027328/doc4.xml","form_type":"4"}},{"id":2799052,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2021-03-09T17:37:46.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":3000,"price":120.69,"value":362070.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.68 to $120.96 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":13544,"source":{"system":"sec-edgar","filing":"0001209191-21-018872","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121018872/doc4.xml","form_type":"4"}},{"id":2811745,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-04T01:43:11.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":4655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":4655,"derivative":{"exercise_price":142.47,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":4655},"source":{"system":"sec-edgar","filing":"0001209191-21-017556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121017556/doc4.xml","form_type":"4"}},{"id":2811744,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2021-03-04T01:43:11.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":732,"price":138.17,"value":101140.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold to pay required tax withholdings due to the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.16 to $138.18 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":16544,"source":{"system":"sec-edgar","filing":"0001209191-21-017556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121017556/doc4.xml","form_type":"4"}},{"id":2811743,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2021-03-04T01:43:11.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":1560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."}],"balance_after":17276,"source":{"system":"sec-edgar","filing":"0001209191-21-017556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121017556/doc4.xml","form_type":"4"}},{"id":2880920,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2021-02-04T01:01:55.000Z","date":"2020-11-06","kind":"gift","acquired":false,"shares":934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":15502,"source":{"system":"sec-edgar","filing":"0001209191-21-007552","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121007552/doc5.xml","form_type":"5"}},{"id":2911962,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Stock Option","published_at":"2021-01-09T00:05:18.000Z","date":"2021-01-07","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter."}],"balance_after":8000,"derivative":{"exercise_price":21,"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-21-002825","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121002825/doc4.xml","form_type":"4"}},{"id":2911961,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2021-01-09T00:05:18.000Z","date":"2021-01-07","kind":"sale","acquired":false,"shares":4000,"price":140.65,"value":562600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.04 to $143.02 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 214 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 31, 2020.  Also reflects dispositions from gifts that will be reported in a Form 5 within 45 days after the Issuer's fiscal year end."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":15716,"source":{"system":"sec-edgar","filing":"0001209191-21-002825","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121002825/doc4.xml","form_type":"4"}},{"id":2911960,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2021-01-09T00:05:18.000Z","date":"2021-01-07","kind":"exercise","acquired":true,"shares":4000,"price":21,"value":84000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":20436,"source":{"system":"sec-edgar","filing":"0001209191-21-002825","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121002825/doc4.xml","form_type":"4"}},{"id":3004883,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2020-10-16T23:16:20.000Z","date":"2020-10-14","kind":"sale","acquired":false,"shares":146,"price":87.98,"value":12845.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":16436,"source":{"system":"sec-edgar","filing":"0001209191-20-055173","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120055173/doc4.xml","form_type":"4"}},{"id":3084803,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-10T21:21:46.000Z","date":"2020-07-08","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter."}],"balance_after":12000,"derivative":{"exercise_price":21,"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-20-042195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120042195/doc4.xml","form_type":"4"}},{"id":3084802,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2020-07-10T21:21:46.000Z","date":"2020-07-08","kind":"sale","acquired":false,"shares":2000,"price":91,"value":182000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":16582,"source":{"system":"sec-edgar","filing":"0001209191-20-042195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120042195/doc4.xml","form_type":"4"}},{"id":3084801,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2020-07-10T21:21:46.000Z","date":"2020-07-08","kind":"exercise","acquired":true,"shares":2000,"price":21,"value":42000.0,"ownership":{"direct":true},"balance_after":18582,"source":{"system":"sec-edgar","filing":"0001209191-20-042195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120042195/doc4.xml","form_type":"4"}},{"id":3084800,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2020-07-10T21:21:46.000Z","date":"2020-07-08","kind":"sale","acquired":false,"shares":638,"price":91,"value":58058.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":16582,"source":{"system":"sec-edgar","filing":"0001209191-20-042195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120042195/doc4.xml","form_type":"4"}},{"id":3088257,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-06T18:21:01.000Z","date":"2020-07-01","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter."}],"balance_after":14000,"derivative":{"exercise_price":21,"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001209191-20-040944","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120040944/doc4.xml","form_type":"4"}},{"id":3088256,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2020-07-06T18:21:01.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":1500,"price":81,"value":121500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":17220,"source":{"system":"sec-edgar","filing":"0001209191-20-040944","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120040944/doc4.xml","form_type":"4"}},{"id":3088255,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2020-07-06T18:21:01.000Z","date":"2020-07-01","kind":"exercise","acquired":true,"shares":1500,"price":21,"value":31500.0,"ownership":{"direct":true},"balance_after":18720,"source":{"system":"sec-edgar","filing":"0001209191-20-040944","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120040944/doc4.xml","form_type":"4"}},{"id":3088254,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2020-07-06T18:21:01.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":1111,"price":81,"value":89991.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":17220,"source":{"system":"sec-edgar","filing":"0001209191-20-040944","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120040944/doc4.xml","form_type":"4"}},{"id":3133275,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2020-05-27T19:14:21.000Z","date":"2020-05-26","kind":"sale","acquired":false,"shares":260,"price":74.93,"value":19481.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":18331,"source":{"system":"sec-edgar","filing":"0001209191-20-032267","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120032267/doc4.xml","form_type":"4"}},{"id":3133274,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2020-05-27T19:14:21.000Z","date":"2020-05-25","kind":"tax_withholding","acquired":false,"shares":433,"price":73.81,"value":31959.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."}],"balance_after":18591,"source":{"system":"sec-edgar","filing":"0001209191-20-032267","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120032267/doc4.xml","form_type":"4"}},{"id":3142174,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-19T23:15:26.000Z","date":"2020-05-15","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter."}],"balance_after":15500,"derivative":{"exercise_price":21,"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001209191-20-030710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120030710/doc4.xml","form_type":"4"}},{"id":3142173,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2020-05-19T23:15:26.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":1500,"price":71,"value":106500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 305 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2020"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":19024,"source":{"system":"sec-edgar","filing":"0001209191-20-030710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120030710/doc4.xml","form_type":"4"}},{"id":3142172,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2020-05-19T23:15:26.000Z","date":"2020-05-15","kind":"exercise","acquired":true,"shares":1500,"price":21,"value":31500.0,"ownership":{"direct":true},"balance_after":20219,"source":{"system":"sec-edgar","filing":"0001209191-20-030710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120030710/doc4.xml","form_type":"4"}},{"id":3142171,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2020-05-19T23:15:26.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":961,"price":71,"value":68231.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":18719,"source":{"system":"sec-edgar","filing":"0001209191-20-030710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120030710/doc4.xml","form_type":"4"}},{"id":3156137,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2020-05-09T00:08:49.000Z","date":"2020-05-06","kind":"tax_withholding","acquired":false,"shares":138,"price":66.26,"value":9143.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":19680,"source":{"system":"sec-edgar","filing":"0001209191-20-028115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120028115/doc4.xml","form_type":"4"}},{"id":3172204,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2020-04-21T19:33:50.000Z","date":"2020-04-19","kind":"tax_withholding","acquired":false,"shares":140,"price":58.57,"value":8199.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":19818,"source":{"system":"sec-edgar","filing":"0001209191-20-025188","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120025188/doc4.xml","form_type":"4"}},{"id":3226593,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-05T00:44:47.000Z","date":"2020-03-01","kind":"grant","acquired":true,"shares":13280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":13280,"derivative":{"exercise_price":56.08,"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":13280},"source":{"system":"sec-edgar","filing":"0001209191-20-016374","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120016374/doc4a.xml","form_type":"4/A","original_submission_date":"2020-03-03"}},{"id":3226592,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2020-03-05T00:44:47.000Z","date":"2020-03-01","kind":"grant","acquired":true,"shares":4400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":19958,"source":{"system":"sec-edgar","filing":"0001209191-20-016374","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120016374/doc4a.xml","form_type":"4/A","original_submission_date":"2020-03-03"}},{"id":3230971,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-04T00:56:53.000Z","date":"2020-03-01","kind":"grant","acquired":true,"shares":7480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":7480,"derivative":{"exercise_price":56.08,"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":7480},"source":{"system":"sec-edgar","filing":"0001209191-20-015757","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120015757/doc4.xml","form_type":"4"}},{"id":3230970,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2020-03-04T00:56:53.000Z","date":"2020-03-01","kind":"tax_withholding","acquired":false,"shares":388,"price":56.08,"value":21759.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":17058,"source":{"system":"sec-edgar","filing":"0001209191-20-015757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120015757/doc4.xml","form_type":"4"}},{"id":3230969,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2020-03-04T00:56:53.000Z","date":"2020-03-01","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":17446,"source":{"system":"sec-edgar","filing":"0001209191-20-015757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120015757/doc4.xml","form_type":"4"}},{"id":3310586,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2020-01-15T18:08:07.000Z","date":"2020-01-14","kind":"sale","acquired":false,"shares":1000,"price":61,"value":61000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 161 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 31, 2019"}],"balance_after":15946,"source":{"system":"sec-edgar","filing":"0001209191-20-003425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120003425/doc4.xml","form_type":"4"}},{"id":3392728,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controller and PAO"}}],"security":"Common Stock","published_at":"2019-10-16T23:21:52.000Z","date":"2019-10-14","kind":"grant","acquired":true,"shares":800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) into which previously granted performance stock units were converted on October 14, 2019 upon certification of the applicable performance metric. Half of these RSUs will vest on the first anniversary of the certification date and the other half will vest on the second anniversary of the certification date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":16785,"source":{"system":"sec-edgar","filing":"0001209191-19-053320","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119053320/doc4.xml","form_type":"4"}},{"id":3508432,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Common Stock","published_at":"2019-05-29T22:36:30.000Z","date":"2019-05-25","kind":"tax_withholding","acquired":false,"shares":433,"price":57.18,"value":24758.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":15985,"source":{"system":"sec-edgar","filing":"0001209191-19-033285","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119033285/doc4.xml","form_type":"4"}},{"id":3514714,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Common Stock","published_at":"2019-05-22T21:46:41.000Z","date":"2019-05-21","kind":"tax_withholding","acquired":false,"shares":156,"price":59.5,"value":9282.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":16418,"source":{"system":"sec-edgar","filing":"0001209191-19-032140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119032140/doc4.xml","form_type":"4"}},{"id":3536254,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Common Stock","published_at":"2019-05-07T22:52:24.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) into which previously granted performance stock units were converted on May 6, 2019 upon certification of the applicable performance metric. Half of these RSUs will vest on the first anniversary of the certification date and the other half will vest on the second anniversary of the certification date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 270 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2019."}],"balance_after":16574,"source":{"system":"sec-edgar","filing":"0001209191-19-028089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119028089/doc4.xml","form_type":"4"}},{"id":3550976,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Common Stock","published_at":"2019-04-23T22:38:09.000Z","date":"2019-04-19","kind":"tax_withholding","acquired":false,"shares":138,"price":64.43,"value":8891.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":15504,"source":{"system":"sec-edgar","filing":"0001209191-19-025620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119025620/doc4.xml","form_type":"4"}},{"id":3553340,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-17T21:59:58.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":6840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":6840,"derivative":{"exercise_price":67.55,"expiration_date":"2029-03-01","underlying":"Common Stock","underlying_shares":6840},"source":{"system":"sec-edgar","filing":"0001209191-19-025117","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119025117/doc4a.xml","form_type":"4/A","original_submission_date":"2019-03-04"}},{"id":3553339,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Common Stock","published_at":"2019-04-17T21:59:58.000Z","date":"2019-03-05","kind":"sale","acquired":false,"shares":254,"price":65.52,"value":16642.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units."}],"balance_after":15642,"source":{"system":"sec-edgar","filing":"0001209191-19-025117","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119025117/doc4a.xml","form_type":"4/A","original_submission_date":"2019-03-04"}},{"id":3553338,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Common Stock","published_at":"2019-04-17T21:59:58.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":1390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":15896,"source":{"system":"sec-edgar","filing":"0001209191-19-025117","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119025117/doc4a.xml","form_type":"4/A","original_submission_date":"2019-03-04"}},{"id":3618042,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-04T22:13:56.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":6840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On the first anniversary of the grant date of the option (the \"Option Anniversary Date\"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date."}],"balance_after":6840,"derivative":{"exercise_price":67.55,"expiration_date":"2029-03-01","underlying":"Common Stock","underlying_shares":6840},"source":{"system":"sec-edgar","filing":"0001209191-19-015752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119015752/doc4.xml","form_type":"4"}},{"id":3618041,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Common Stock","published_at":"2019-03-04T22:13:56.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":246,"price":67.55,"value":16617.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."}],"balance_after":15649,"source":{"system":"sec-edgar","filing":"0001209191-19-015752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119015752/doc4.xml","form_type":"4"}},{"id":3618040,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Common Stock","published_at":"2019-03-04T22:13:56.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":1390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":15895,"source":{"system":"sec-edgar","filing":"0001209191-19-015752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119015752/doc4.xml","form_type":"4"}},{"id":3712650,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-03T00:21:20.000Z","date":"2019-01-02","kind":"exercise","acquired":false,"shares":2448,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the option vested one year from January 29, 2014 and then 1/48th monthly thereafter."}],"balance_after":17000,"derivative":{"exercise_price":21,"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":2448},"source":{"system":"sec-edgar","filing":"0001209191-19-000500","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119000500/doc4.xml","form_type":"4"}},{"id":3712649,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Common Stock","published_at":"2019-01-03T00:21:20.000Z","date":"2019-01-02","kind":"exercise","acquired":true,"shares":2448,"price":21,"value":51408.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 117 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 31, 2018."}],"balance_after":14505,"source":{"system":"sec-edgar","filing":"0001209191-19-000500","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119000500/doc4.xml","form_type":"4"}},{"id":3892132,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T23:55:47.000Z","date":"2018-06-15","kind":"exercise","acquired":false,"shares":2955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the option vested one year from January 29, 2014 and then 1/48th monthly thereafter."}],"balance_after":19448,"derivative":{"exercise_price":21,"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":2955},"source":{"system":"sec-edgar","filing":"0001209191-18-038210","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118038210/doc4.xml","form_type":"4"}},{"id":3892131,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Common Stock","published_at":"2018-06-15T23:55:47.000Z","date":"2018-06-15","kind":"sale","acquired":false,"shares":955,"price":83.7,"value":79933.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":11940,"source":{"system":"sec-edgar","filing":"0001209191-18-038210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118038210/doc4.xml","form_type":"4"}},{"id":3892130,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Common Stock","published_at":"2018-06-15T23:55:47.000Z","date":"2018-06-15","kind":"exercise","acquired":true,"shares":2955,"price":21,"value":62055.0,"ownership":{"direct":true},"balance_after":12895,"source":{"system":"sec-edgar","filing":"0001209191-18-038210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118038210/doc4.xml","form_type":"4"}},{"id":3895077,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Common Stock","published_at":"2018-06-13T22:41:38.000Z","date":"2018-06-13","kind":"sale","acquired":false,"shares":1338,"price":76.97,"value":102985.86,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":9940,"source":{"system":"sec-edgar","filing":"0001209191-18-037560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118037560/doc4.xml","form_type":"4"}},{"id":3915079,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":51309,"kind":"person","name":"Huizenga Theodore Alan","position":1,"cik":"0001603347","reported_name":"Huizenga Theodore Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Common Stock","published_at":"2018-05-29T17:28:15.000Z","date":"2018-05-25","kind":"tax_withholding","acquired":false,"shares":433,"price":67.31,"value":29145.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":11278,"source":{"system":"sec-edgar","filing":"0001209191-18-033718","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118033718/doc4.xml","form_type":"4"}}],"next_cursor":"2018-05-29T17:28:15.000000Z,3915079"}